Shares of Immune Pharmaceuticals Inc.
IMNP, -5.36%
slid 9% in premarket trade Monday, after the company unveiled a restructuring and said it has received notice from the Nasdaq that it is not in compliance with listing requirements after the delay of a key regulatory filing. Immune Pharma…
Read the full article at: http://www.marketwatch.com/story/immune-pharma-shares-tumble-9-premarket-as-it-unveils-restructuring-2017-04-24